- Home
- Publications
- Publication Search
- Publication Details
Title
A review of olanzapine pamoate
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 13, Issue 11, Pages 1661-1670
Publisher
Informa Healthcare
Online
2012-06-30
DOI
10.1517/14656566.2012.686169
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia
- (2011) Angela L Hill et al. BMC Psychiatry
- Cost-effectiveness of olanzapine long-acting injection in the treatment of patients with schizophrenia in the United States: a micro-simulation economic decision model
- (2011) Nicolas M. Furiak et al. CURRENT MEDICAL RESEARCH AND OPINION
- Olanzapine pamoate for the treatment of schizophrenia
- (2011) Dieter Naber EXPERT OPINION ON PHARMACOTHERAPY
- Oral versus depot antipsychotic drugs for schizophrenia—A critical systematic review and meta-analysis of randomised long-term trials
- (2011) Claudia Leucht et al. SCHIZOPHRENIA RESEARCH
- Antipsychotic treatment for schizophrenia in the maintenance phase: A systematic review of the guidelines and algorithms
- (2011) Hiroyoshi Takeuchi et al. SCHIZOPHRENIA RESEARCH
- Practical Limitations of Prescribing Olanzapine Depot (Relprevv)
- (2010) Peter Devadason Australasian Psychiatry
- Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases
- (2010) Holland C Detke et al. BMC Psychiatry
- Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism
- (2010) David P McDonnell et al. BMC Psychiatry
- Olanzapine Long-Acting Injection
- (2010) James E. Frampton DRUGS
- Long-acting atypical injectable antipsychotics in the treatment of schizophrenia: safety and tolerability review
- (2010) Fernando Cañas et al. Expert Opinion On Drug Safety
- Dose correspondence between olanzapine long-acting injection and oral olanzapine
- (2010) Holland C. Detke et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Targeting of the Orphan Receptor GPR35 by Pamoic Acid: A Potent Activator of Extracellular Signal-Regulated Kinase and -Arrestin2 with Antinociceptive Activity
- (2010) P. Zhao et al. MOLECULAR PHARMACOLOGY
- Schizophrenia, “Just the Facts” 5. Treatment and prevention Past, present, and future
- (2010) Rajiv Tandon et al. SCHIZOPHRENIA RESEARCH
- Resurgence of Long-Acting Antipsychotic Formulations
- (2010) Steven J. Siegel Current Psychiatry Reports
- Profile of olanzapine long-acting injection for the maintenance treatment of adult patients with schizophrenia
- (2010) Rosaria rosaria di lorenzo Neuropsychiatric Disease and Treatment
- Long-acting injectable antipsychotics: focus on olanzapine pamoate
- (2010) Jean-Pierre Lindenmayer Neuropsychiatric Disease and Treatment
- Olanzapine Long-Acting Injection: A 24-Week, Randomized, Double-Blind Trial of Maintenance Treatment in Patients With Schizophrenia
- (2009) John M. Kane et al. AMERICAN JOURNAL OF PSYCHIATRY
- Second-generation antipsychotic long-acting injections: Systematic review
- (2009) W. Wolfgang Fleischhacker BRITISH JOURNAL OF PSYCHIATRY
- Olanzapine pamoate - blockbuster or damp squib?
- (2009) D. M. Taylor INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Comparison of treatment completion rates for olanzapine pamoate and risperidone microspheres
- (2009) K. S. Akhras et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- An 8-Week, Double-Blind, Randomized, Placebo-Controlled Study of Olanzapine Long-Acting Injection in Acutely Ill Patients With Schizophrenia
- (2009) John Lauriello et al. JOURNAL OF CLINICAL PSYCHIATRY
- Upcoming Agents for the Treatment of Schizophrenia
- (2008) Delia Bishara et al. DRUGS
- P.3.c.059 Post-injection delirium/sedation syndrome observed with olanzapine long-acting injection: review of the first 25 events
- (2008) D. McDonnell et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Olanzapine pamoate: a stick in time?
- (2008) L. Citrome INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia
- (2008) Rajiv Tandon et al. SCHIZOPHRENIA RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started